Remdesivir's Deadly 53% Mortality Rate Exposed

Dr. Bryan Ardis reveals the shocking truth about remdesivir's clinical trial results.

The drug was pulled from Ebola trials after showing a devastating 53% mortality rate—higher than the death rate of Ebola itself.

Despite being the worst-performing drug in the study, remdesivir was later approved for COVID-19 treatment.

Learn the disturbing facts about this pharmaceutical disaster and why this information is critical for making informed health decisions.

The truth about remdesivir's deadly track record cannot be ignored.

#remdesivir #mortalityrates #PharmaExposed #healthtruths #covid19